Joshua Yang
Josh is the co-founder and CEO of Glyphic Biotechnologies, a VC-funded biotechnology startup commercializing a next-generation protein sequencing platform. His first-author, peer-reviewed publications have been published in top-tier journals such as Nature Reviews Genetics and Science Translational Medicine. He is also an inventor on 6 issued/filed patents and author on 18 research articles. He was named to the Forbes 30 Under 30 Healthcare list and awarded a Biocom California Catalyst Award in 2021. In his free time, he enjoys going to farmer's markets on Sunday mornings, sipping on dirty chai lattes, and creating pastries from scratch.